WFLA’s health program Bloom recently featured an in-depth segment on hormone replacement therapy (HRT) for women navigating perimenopause and menopause, highlighting the evolving medical understanding of treatment options during this critical life transition. The segment comes at a time when attitudes toward HRT are shifting among both healthcare providers and patients, following decades of confusion sparked by earlier controversial studies.
Perimenopause, the transitional phase before menopause that can begin in a woman’s 40s or even earlier, often brings debilitating symptoms including hot flashes, night sweats, mood changes, and sleep disturbances. Full menopause is confirmed after 12 consecutive months without menstruation, but the symptomatic period can last several years. HRT, which typically involves estrogen alone or combined with progesterone, remains the most effective treatment for managing these symptoms and can also help prevent bone loss associated with declining estrogen levels.
The medical community’s approach to HRT has evolved significantly since the Women’s Health Initiative study in 2002 raised concerns about cardiovascular and cancer risks. More recent research has refined understanding of when HRT is appropriate, showing that for many women—particularly those under 60 or within 10 years of menopause onset—the benefits often outweigh potential risks. However, treatment must be individualized based on personal and family health history.
For patients experiencing menopausal symptoms, the Bloom segment underscores the importance of having informed conversations with healthcare providers about all available options. Women no longer need to simply endure symptoms that can significantly impact quality of life, work performance, and relationships. As medical understanding continues to advance, the key is finding qualified practitioners who stay current with evolving evidence and can provide personalized guidance rather than applying one-size-fits-all recommendations.
